Maureen Kenny

Novartis Restructure: With top names departing, refocused therapeutic priorities & new targets set, this @PharmaScrip article by @awmcconaghie is important reading for all in the industry, from biotech partners (and would-be partners) to big pharma peers. bit.ly/3v3BmD1

Alexander Natz of @EUCOPE explains in this @PharmaPinkSheet article the new EU regulation on health technology assessment, one of the biggest developments to affect the pharma industry in over a decade. bit.ly/3ugfQvI

Welcome to #DIAEurope2022 ! #Day1 we are so excited to be face-to-face in Brussels! Our three-day event is just beginning, there is still time to attend! Click here to register today: ow.ly/VavS50Is9sA

And on St Patrick's Day! Congrats to Lorraine Nolan and to @TheHPRA. #pharma #appointments

This first edition of Report Digest from @PharmaPinkSheet sister publication @Medtech_Insight covers the liquid biopsy for oncology market. The podcast considers the main market drivers and what might occur in the sector in future years. bit.ly/3Bkz3ys

This free-to-view article from @PharmaPinkSheet sister publication @Genericbulletin highlights the off-patent industry's involvement in fighting the COVID-19 pandemic in 2021. bit.ly/34MCsKe

Digital therapeutics are expected to play an ever-bigger role in the treatment & management of diseases. @medtechMarion reports in this free @INVIVOnow article that this subcategory of the digital health solutions market could be worth $9bn by 2025. bit.ly/3gzRmpE

This free-to-view timeline from @PharmaPinkSheet is one of a three-part Drug Review Profile package comparing how @US_FDA and @EMA_News reviewed @JanssenGlobal's MS drug Ponvory. Our signature deep-dive DRPs are of interest to drug developers everywhere. bit.ly/3rOSYm5

The @EMA_News is in overdrive on the coronavirus front. Read our @PharmaPinkSheet coverage of the latest developments, by @ScripIanS. bit.ly/3yxtbQN

"We need help." "Everybody is under severe pressure here." "We have [an] increasing number of staff on long-term sick leave." Frank talk from @EMA_News head Emer Cooke. #Covid #workload Read the full free-to-view article by @PharmaPinkSheet's @ScripIanS: bit.ly/3lziEQ2

Plenary 3: @runnerosborn of @pfizer discusses innovation of medicines and vaccines have never been more exciting, seeing a real increase in volume and speed coming through pipeline, specifically for personalized medicine treatment. #ISPOREurope

Best Contract Research Organization - Specialist Providers Award goes to…MMS Holdings! Congratulations! #ScripAwards

Moderna’s Phase III COVE study of mRNA-1273 for COVID-19 prevention has also won the category for Clinical Advance of the Year - COVID-19 Pandemic Special Recognition Award – Sponsored by Parexel – well done! #ScripAwards

Congratulation to both BenevolentAI and AstraZeneca for AI and machine learning to discover potential new treatments for chronic kidney disease and idiopathic pulmonary fibrosis and are taking home the trophy for Best Partnership Alliance #ScripAwards

The winners of the Clinical Advance of the Year - COVID-19 Pandemic Special Recognition Award – Sponsored by Parexel are CluePoints, BioNTech and Pfizer’s Phase I/II/III study of SARS-COV-2 RNA vaccine BNT162b2 (Comirnaty) – congratulations! #ScripAwards

The Award for China Biopharma Leadership Award goes to… BeiGene China Congratulations! #ScripAwards

WuXi AppTec's Biotech Company of the Year Award goes to… ADC Therapeutics! Congratulations to the team! #ScripAwards

This year’s Community Partnership of the Year Award goes to Accord Healthcare and International Health Partners – well done on your win! #ScripAwards

The Award for Best New Drug Award - non COVID-19 has been awarded to GlaxoSmithKline’s Blenrep (belantamab mafodotin) for multiple myeloma #ScripAwards

The Clinical Advance of the Year Award is Sponsored by Parexel and the winner is Takeda Pharmaceutical Company's Phase III SOLSTICE trial of maribavir in transplant recipients with CMV infection #ScripAwards